Exco InTouch, the leading provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, today announced that it has now formally received U.S.- EU Safe Harbor Framework and U.S.- Swiss Safe Harbor Framework Self Certification status by the U.S. Department of Commerce’s International Trade Administration (ITA). The designation certifies that Exco InTouch’s practices meet or exceed the data privacy and security standards outlined by The European Commission’s Directive on data protection.
The U.S. Department of Commerce, in consultation with the European Commission, developed the Safe Harbor framework in order to bridge the gap between EU/Switzerland and U.S. approaches to privacy protection and provide a streamlined means for U.S. organisations to comply with the Commission’s Directive. In order to be recognised for the certification, Exco InTouch has demonstrated that its customer privacy procedures comply with the seven ‘Safe Harbor Privacy Principles’ which cover notice, choice, transfers to third parties, access, security, data integrity and enforcement. As a result, Exco InTouch’s customers, for whom the company provides mobile and digital patient engagement solutions, can be reassured that their programs comply with these stringent privacy and security safeguards.
“Protecting the privacy and confidentiality of personal information has always been, and will remain, the highest priority for Exco InTouch,” says Mike Hansen, COO and Co-Founder of Exco InTouch. “The U.S. – EU and US – Swiss Safe Harbor Certification will not only help to streamline our data transfer processes between the EU/Switzerland and U.S, but will also provide our customers with further reassurance that we are fully compliant with the highest standards of data protection.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Looking Forward in the Feasibility/AI Space
May 6th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Rohit Nambisan, CEO & founder of Lokavant looks into the future of feasibility studies, the integration of AI, and how they are driving more personalized approaches.